Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Jeffrey H NewcornPeter NagyAnn C ChildressGlen FrickBrian YanSteven PliszkaPublished in: CNS drugs (2018)
NCT01552915 and NCT01552902.
Keyphrases
- placebo controlled
- double blind
- liver failure
- phase iii
- young adults
- clinical trial
- phase ii
- attention deficit hyperactivity disorder
- respiratory failure
- study protocol
- physical activity
- phase ii study
- aortic dissection
- drug induced
- squamous cell carcinoma
- autism spectrum disorder
- hepatitis b virus
- working memory
- radiation therapy
- mechanical ventilation
- locally advanced